Biggest News Aggregation in the World
📰 Technology Platform News

Page 157 - Technology Platform News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Technology Platform. Real-time updates on events, politics, business and more.

The global laboratory informatics market was valued at $4,341.2 million in 2021 and is anticipated to reach $12,677.0 million by 2032, witnessing a CAGR of 10.27% during the forecast period 2022-2032

/PRNewswire/ -- Global Laboratory Informatics Market to Reach $12,677.0 Million by 2032 Global Laboratory Informatics Market Industry Overview Read the full...
United States South Korea Fisher Chromeleon Agilent Technologies Inc Electronic Lab Notebooks Amazon Web Services

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

IND approval from the US FDA for theranostic SAR-Bombesin trial in prostate cancer

SYDNEY, Nov. 21, 2022 /PRNewswire/ -- Highlights Clarity's fifth successful Investigational New Drug (IND) application with the United States Food and Drug Administration (US FDA), opening up therapeutic applications for SAR-Bombesin A total of six products with both the diagnostic and therapeutic applications for SARTATE, SAR-bisPSMA and SAR Bombesin are now under IND for US clinical trials First therapeutic clinical program for SAR-Bombesin will be in PSMA negative metastatic castrate resi...
United States New South Wales Alan Taylor Guggerm Bombesin Clarity Pharmaceuticals National Cancer Institute

TPT Global Tech, Inc.: TPT GLOBAL TECH subsidiary Blue Collar Productions Continues Growth in Entertainment Marketing and Content Creation as year ends

SAN DIEGO, CA / ACCESSWIRE / November 21, 2022 / TPT Global Tech, Inc. ("TPTW" or the "Company") (OTC PINK:TPTW) today announced its "Blue Collar Productions" subsidiary, announced today it has experienced
United States San Diego Marvin Gaye Mark Rowen Ted Lasso Walt Disney Company

IND approval from the US FDA for theranostic SAR-Bombesin trial in prostate cancer

SYDNEY, Nov. 21, 2022 /PRNewswire/ -- Highlights Clarity's fifth successful Investigational New Drug (IND) application with the United States Food and Drug Administration (US FDA), opening up therapeutic applications for SAR-Bombesin A total of six products with both the diagnostic and therapeutic applications for SARTATE, SAR-bisPSMA and SAR Bombesin are now under IND for US clinical trials First therapeutic clinical program for SAR-Bombesin will be in PSMA negative metastatic castrate resi...
United States New South Wales Alan Taylor Guggerm Bombesin Clarity Pharmaceuticals National Cancer Institute

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science